CS
MNTA

Credit Suisse’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Credit Suisse’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-15,000
Closed -$175K – 4869
2014
Q1 		$175K Buy
+15,000
New +$254K ﹤0.01% 4397

Credit Suisse's MNTA Position: Q4 2020 in Review

Credit Suisse sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 330,524 shares — an estimated $17.3M sold.

Credit Suisse first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $17.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Credit Suisse reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Credit Suisse sold 330,524 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $17.3M.
  • Credit Suisse first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
  • Credit Suisse's Momenta Pharmaceuticals, Inc. position peaked at $17.3M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Credit Suisse's 13F filing for Q4 2020, filed 12 Feb 2021.